The bleomycins are a group of antibiotics produced by Streptomyces verticillus and their therapeutic effect against the squamous cell carcinoma has been proved by clinical studies. In our laboratory, eight products, viz. bleomycin A 1 , demethyl-A 2 , A;-a, A;-b, B 2 , A 5 and B 4 have been isolated in the pure state. Structures of the various bleomycins have been elucidated and it has been observed that they differ from each other in the amine moiety. The addition of an amine, especially diamines and triamines, during fermentation, induced the production of the bleomycin containing the amine added and suppressed the production of other bleomycins. Thus, 42 artificial bleomycins were synthesized and their biological activities studied. The selective effect against squamous cell carcinoma and the mechanism of the selective activity that was shown by an enzymatic inactivation will be discussed. A partial purification ofthe inactivating enzyme has been achieved.
In the study started from phleomycin 1 • 2 , we found a group of antibiotics which were produced by Streptomyces verticillus and were ditl'erentiated from phleomycin by paper chromatography and stability in aqueous solution. Phleomycin caused irreversible renal darnage but this antibiotic did not, and we named this antibiotic bleomycin 3 • 4 • Bleomycin has been confirmed tobe effective against squamous cell carcinoma and it is used for treatment of this type of human cancer. Bleomycins which are obtained from the culture filtrate by cation exchange resirr process, carbon chromatography and alumina chromatography are in their copper-chelated forms. Both the copper-chelated and the copper-free bleomycins are equally active and copper-free bleomycin mixture is used clinically. In the second paper, we reported bleomycins Ab A 2 , A 3 , A 4 , A 5 , A 6 , Bll B 2 , B 3 , B 4 and B 5 • Later, we found demethyl-A 2 , A;-a, A;-b, B' 1 and B 6 . These bleomycins were separated by CM-Sephadex C-25 column chromatography raising the concentration of ammonium formate from 0.05M to l.OM. An example of the chromatography is shown in Figure 1 . All bleomycins have the maximum at 292 IDJ.l and the absorption of the eluate at this wavelength was determined.
A 1 and demethyl-A 2 which appeared in peaks I and II respectively were separated by co1umn chromatography of Dowex 50 resin treated with 0.2M pyridine acetate butl'er at pH 4.4. The elution was carried out by raising the pH of the same buffer from pH 4.4 to 5.5 . The separation of A2-a and A2-b, both of which appeared in the peak V, was accomplished by repetition of CM-Sephadex C-25 chromatography, raising the concentration of ammonium formate from 0.05M to 0.5M. One of the objects of our bleomycin study was to find the chemical differences between thesenatural bleomycins and to establish a method of fermentation to produce a single bleomycin.
If it was successful, based on the biological activity of each bleomycin we thought that we could find more active bleomycins against squamous cell carcinoma than the present one. As we have reported in this paper, all bleomycins were different in their amine moiety and, on the basis of this observation, we were able to establish a method of fermentation to produce artificial bleomycins. By addition of an amine, especially a diamine or a triamine, to the fermentationmedium bleomycin containing the amine added was selectively produced. Thus, we were able to prepare forty-two bleomycins. Now we need the fundamental basis which could be used to predict the efficiency of each bleomycin against squamous cell carcinoma in humans.
In this paper, we will report the chemical differences between natural bleomycins, preparation of artificial bleomycins by fermentation and the enzymatic inactivation of bleomycins which is one of the mechanisms of the selective effect against the squamous cell carcinoma. The study of the structure ofbleomycin A 2 , which is the main component of bleomycin employed clinically, is now being continued by Takita, Muraoka, Omoto, Maeda and the author The hydrolysis of bleomycin A 2 in 6N hydrochloric acid at 37°C for four days gives the tripeptide S and the tripeptide A. The total acid hydrolysis ofthe tripeptide A in 6N hydrochloric acid gives four amino acids: ß-amino-ß-(4-amino-6-carboxy-5-methylpyrimidin-2-yl)-propionic acid (II), L-ß-aminoalanine (V), ß-hydroxyhistidine (IV) and 4-amino-3-hydroxy-2-methyln-valeric acid (III). Because of this tripeptide A was described as a tetrapeptidein previous papers. The structure ofthe amino acid II-V in Figure 2 , which gave II and V by acid degradation, was recently determined by 666 NATURAL AND ARTIFICIAL BLEOMYCINS Tripeptide S: its synthesis from II and the methyl ester of et-acetylaminoacrylic acid. As shown in Figure 2 , the acid hydrolysis of the tripeptide S gives L-threonine (I), 2'-(2-aminoethyl)-2,4'-bithiazole-4-carboxylic acid (VI) and 3-aminopropyl-dimethylsulphonium (VII). We could find a hydrolysis condition for bleomycins, that is, in 0.3N sulphuric acid at 81-83oC for 6 hours, to give the sugar moiety in the dissaccharide form, as shown in Figure 2 . L-Gulose and 3-0-carbamoyl-nmannose in bleomycins can be identified by gas1.chromatography of the trimethylsilyl derivatives of the products obtained by ieflux of bleomycins in methanol with strong acidic resin (Amberlyst 15) for 30 hours. The pattern of a gas chromategram is shown in Figure 3 . The other peaks D and F appeared together with A in the gas chromatography of trimethylsilyl methyl et-o-gulopyranoside. The patterns of the gas chromatography of trimethylsilyl derivatives of the methanolysis products · of natural bleomycins were the same and therefore the sugar moiety was confirmed to be the same in natural bleomycins. Six amino acids and an amine obtained by the total hydrolysis of bleomycins can be identified by high voltage electrophoresis in formic acid-acetic acid-water (25:75:900) followed by ascending paper chromatography using n-propanol-pyridine-acetic acid-water (15: 10:3: 12). The result for bleomycin A 2 is shown in Figure 4 . By this method, the amine moiety was found to be different in natural bleomycins. The amines of bleomycins were isolated and their structures were studied by Fujii, Takita and the author. The bleomycins were hydrolysed in 6N hydrochloric acid at 105°C for 30 hours and, after evaporation to dryness, dissolved in distilled water and passed through a column of Dowex-1 in OH form. Then, the amines appeared in the effluent and were crystallized as picrates.
NATURAL AND ARTIFICIAL BLEOMYCINS
The amine from B 2 :
The amine from A 6 :
The amine of B 2 was obtained as the dipicrate: m.pt 238-239°C, C 5 H 14 N 4 ·2(C 6 H 3 N 3 0 7 ). The guanidine group was shown by Sakaguchi reaction and the amino group by positive ninhydrin and one mole of V an Slyke nitrogen. The result of the eiemental analysis conforms to the formula in Figure 5 . Two middle methylene groups were shown by the multiplet signals of four protons at 2.18<5 and the methylene groups adjacent to amino and guanidine groups were shown by the triplet of pairs of protons at 3.52<5 and at 3.71<5 (in D 2 0) respectively. The identity with agmatine was confirmed by comparison with an authentic sample.
The amine of bleomycin A 5 was first crystallized as the tripierate and was converted to the trihydrochloride, m.pt 247-248°C, C 7 H 19 N 3 · 3HCI. The result of the eiemental analysis, positive ninhydrin, two moles of V an Slyke nitrogen and n.m.r. data obtained by the decoupling, suggested that this amine was spermidine. The identity with spermidine was proved by comparison with an authentic sample.
The amine of A 6 was crystallized as the tetrapicrate, m.pt 249-250°C (dec), C 10 H 26 N 4 · 4(C 6 H 3 N 3 0 7 ). The amine of A 5 was spermidine and, therefore, from the result of eiemental analysis we suspected the amine of A 6 to be spermine. The identity with spermine was confirmed by comparison of melting point, behaviour in high valtage electrophoresis, thin layer chromatography in several solvents, infra-red spectrum and gas chromatography with an authentic sample. The amine of B 4 was first crystallized as the picrate, C 10 H 25 N 7 · 3(C 6 H 3 N 3 0 6 ), m.pt 194-195°C, decomposition at 203°C, and it was converted to its sulphate by the procedure using Dowex-1 resin in OH form, C 10 H 25 N 7 ·1.5 H 2 S0 4 , m.pt 270-272oC (dec). The molecular weight 377 was obtained by titration (pK~ 10·2 and > 12). It·was positive in ninhydrin and Sakaguchi and gave one mole of V an Slyke nitrogen.
Coupling of bcfg with a and deh protons ( Figure 6 ) was shown by irradiating to bcfg: a and deh signals turned to a broad singlet. The N -monoacetyl derivative was crystallized as the dipicrate, m.pt 173-173.5°C, C 10 H 24 N 7 • CH 3 C0·2(C 6 H 3 N 3 0 7 ). In this monoacetate the signal of a in the previous compound shifted to Iower field and was assigned to the methylene adjacent to the acetylated amino group. The treatment of the B 4 sulphate in 1N sodium hydroxide at 105°C for 45 hours gave a urea derivative (Figure 6 ), putrescine and ammonia. The ureaderivative was crystallized as its dipicrate,
The amine of B 4 : 
To obtain the tripeptides containing the amine from bleomycins A 1 , demethyl A 2 , A 2 , B 2 , A 5 , B 4 and A 6 , hydrolysis in concentrated hydrochloric acid (12N), at 27oC for 2-3 days, was the most suitable condition. The hydrolysate was evaporated to dryness and was subjected to column chromatography on CM-Sephadex C-25 which was treated with 0·05M ammonium formate. The chromategram was developed, raising the concentration of ammonium formate from 0·05M to l·OM continuously. The optical density of the eluate at 292 IDJ.l was determined for each fraction. The pattern of the hydrolysate of B 2 is shown in Figure 7 . The penultimate peak corresponds to the tripeptide consisting of L-threonine (1), the bithiazole amino acid (VI) and the amine, and the last one corresponds to the dipeptide consisting of the bithiazole amino acid and the amine. 
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The amine of deamino-A 5 :
As _f;:n-r.,.ntin mn-rrP_~rPn.~ A~-b Figure 7 indicates that the tripeptide or the dipeptide of B 2 containing the amine appears in the Iater fraction. In the case of B 4 containing the more basic amine, it was necessary to use 2M ammonium formate for elution of the tri-and dipeptides.
Here we describe the isolation of the tripeptide from bleomycin A 5 • The tripeptide appeared in the fractions eluted with 0.91-l.OM ammonium formate and crystallized from aqueous ethanol as the trihydrochloride, m.pt 196-1970C (dec), C 20 H 33 N 7 0 3 S 2 · 3HC1. The dipeptide consisting of the bithiazole amino acid and spermidine was obtained from a peak which appeared in the eluate with l.OM ammonium formate. The total hydrolysis ofthe tripeptide gave L-threonine (I), the bithiazole amino acid (VI) and spermidine. The hydrolysis of the tripeptidein 6N hydrochloric acid at 105°C for 1 hour gave a dipeptide which was separated by high voltage paper electrophoresis (Rm 0.56, taking L-alanine as 1.0). The amino terminal was shown to be L-threonine and total hydrolysis gave L-threonine and the bithiazole amino acid. Thus, the structure of the tripeptide obtained by partial hydrolysis of A 5 is shown in Figure 8 . However, it must be determined which ammo group of spermidine forms the amide bond with the carboxyl group of the bithiazole amino acid. The coupling of the middle methylene protons of the trimethylene group with methylene adjacent to the amide was shown by irradiating to 2.506. The triplet at 3.986 became the singlet. In spermidine, the signaloftbis methylene appeared at 3.706. The shift to 3.986 suggests that the amino group adjacent to this methylene participates in binding with the bithiazole amino acid. Bleomycin A 5 was deaminated by treatment with sodium nitrite, deaminobleomycin A 5 was hydrolysed in 6N HCI at 105°C for 30 hours and deaminospermidine was crystallised as the picrate, m.pt 166-167°C, C 7 H 18 N 2 0(C 6 H 3 N 3 0 7 ) 2 . This deaminospermidine was compared with N -(3-hydroxypropyl)-1,4-diaminobutane and 4-(3-aminopropylamino )-1-butanol by infra-red spectrum, melting point, behaviour on high voltage electrophoresis and thin layer chromatography, and the identity with 4-(3-aminopropyl)-1-butanol was confirmed. Thus, the amino group of spermidine binding with the carboxyl group of the bithiazole amino acid was determined. Bleomycin A 5 (50 mg, copper-free) was converted to another bleomycin by shaking with dried cells (50 mg) of Serratia marcescens in phosphate bufferat pH 6.8 for three days. After this reaction, this bleomycin was purified by CM-Sephadex C-25 chromatography, raising the concentration of ammonium formate from 0.05M to l.OM. The amine part of this bleomycin was found to be 1 .3-diaminopropane.
The amine of A2-a:
The amine of A2-b: Bleomycin A2-a and A2-b were hydrolysed and the amines were separated and identified as 1,4-diaminobutane and 1,3-diaminopropane respectively.
After A 2 bad been kept in the air for a year, chromatographic analysis indicated the appearance of A 1 and demethyl-A 2 • The methyl signal appeared at 3.20c5 in the n.m.r. spectrum of A 1 and at 2.50c5 for demethyl-A 2 . We confirmed the methyl signal of dimethylsulphoxide at 3.20c5 and the methyl signal of dimethylsulphide at 2.50c5. Thus, these n.m.r. data suggested the amines of A 1 and demethyl-A 2 as those shown in Figure 9 . Recently we succeeded in obtaining A 2 from demethyl-A 2 by the reaction with methyl iodide and we were able to obtain A 1 by treatment of demethyl-A 2 with hydrogen peroxide at room temperature for 30 minutes. Pyrolysis of A 2 at 100°C for several hours gave demethyl-A 2 . Thus, the amine parts of A 1 and demethyl-A 2 were determined.
The differences in the amine moieties of natural bleomycins suggested to us that addition of an amine to the fermentation medium would induce the preferential production of the bleomycin containing the amine added. We thought also that it would be possible to produce artificial bleomycins by adding amines which were not in natural bleomycins. In fact, we have obtained the results expected.
The one methyl carbon (2 x 10 8 cpm)-labelled 3-aminopropyldimethylsulphonium (90 mg) was added to one hundred millilitres medium at 48h of the shaking culture of S. verticillus and it was further shake-cultured for six days. The bleomycin was extracted by IRC-50(H) column chromatography, carbon chromatography and alumina chromatography and the bleomycin mixture obtained was analysed by CM-Sephadex C-25 column chromatography. As shown in Figure 10 , if the result is compared with that in Figure 1 , bleomycin A 2 (the total counts 6.9 x 10 6 cpm) was preferentially produced. Another radioactive peak shows no absorption at 292 mJ..L and therefore it is not a bleomycin. Among the other two small radioactive peaks, peak IV may be a new bleomycin because it was also detected by absorption at292mJ.1. The bleomycins produced by addition of an amine to the fermentation medium were analysed by CM-Sephadex C-25 column chromatography. The results are summarized in Table 1 . Addition of 3-aminopropyl-methylsulphoxide or 3-aminopropyl-methylsulphide did not increase the production of the bleomycins containing these amines. The Chromatographie patterns were almost similar to those of bleomycins produced without addition of an amine. Addition of 3-aminopropyl-dimethylsulphonium increased the production of A 2 . Addition of putrescine increased the production of the corresponding bleomycin. However, the precursor effect of 1,3-diaminopropane was more marked than putrescine.lt can be thought that putrescine is more easily metabolized than 1,3-diaminopropane. Addition of agmatine increased the production of B 2 and B~. This result suggests that bleomycin B~ might contain the amine which could be produced from agmatine. Addition of the amine of B 4 increased B 4 markedly because, without addition of the amine, content of B 4 among bleomycins produced was 2.39 per cent and was increased to 45 per cent by addition of the amine. B 6 seemed to be slightly increased by addition of the amine of B 4 . Another unidentified bleomycin was produced by addition of the amine of B 4 , and its proportion amongst bleomycins was about 40 per cent. This bleomycin appeared in fractions corresponding to B 2 during the CM-Sephadex C-25 chromatography but it was negative in Sakaguchi reaction. lt is thought to contain the amine which might be produced by metabolism of the amine of the material B 4 .
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By addition of spermidine at 360 J.tg/ml to the medium, production of bleomycins other than bleomycin A 5 was almost completely suppressed and, in the medium, A 5 almost alone was produced. Addition of spermine did not cause the production of A 6 but A 5 was produced. It can be thought that spermine was converted to spermidine before incorporation into the bleomycin. Thus, we found that the addition of an amine increases the proportion of the bleomycin containing that amine added amongst the bleomycins produced and, in the case when the amine is metabolized to another amine, the bleomycin containing the latter is produced.
Ethylamine added to the medium is taken into the bleomycin and thirty per cent of the bleomycins produced was the bleomycin containing this amine. Diaminoethane, 1,3-diaminopropane and their N-alkyl or N-aminoalkyl derivatives were more effective precursors and the bleomycins containing these amines were exclusively produced in the fermentation media. More than forty-two bleomycins have been prepared by Nakayama and others, in the Research Laboratories of Nippon Kayaku Co., and their activities have been studied by Matsuda and others in that company. The activities against M ycobacterium 607 and B. subtilis, 50 per cent effective daily dose for ten days and therapeutic indices against the ascites form of Ehrlich carcinoma of seven artificial bleomycins, in the copper-chelated state, are shown in Table 2 .
In general, bleomycins containing diamines are less effective against microorganisms than those containing triamines. However, in general, a 676 50 per cent effective dose against the ascites form of Ehrlich carcinoma was 0.19-0.39 mgjkg. The 50 per cent Iethai daily dose for 10 days varied and the therapeutic indices were generally higher in bleomycins containing triamines than in those containing diamines. It is hard to find a rule among the structure-activity relationships from the present biological data. Besides the fundamental pharmacological data and the data of testing the effect against experimental animal tumours, information on the mechanism of action and the mechanism of the selective effect against squamous cell carcinoma would be useful.
As we have reported 9 - 11 , bleomycins react with DNA and cause strand scission. This reaction is promoted by a sulphhydryl compound, hydrogen peroxide, ascorbic acid etc. Recently, Ono et al., Cancer Research Institute, Tokyo, reported the inhibition of ligase at a lower concentration of bleomycin than that shown by DNA strand scission, though the possibility still remained that the effect on the ligase was due to DNA strand scission. The selective effect of bleomycin on squamous cell carcinoma has been shown by Ichikawa et al., testing the effect on squamous ce11 carcinoma and sarcoma of mice induced by 20-methylcholanthrene. Bleomycin A 2 was effective on this squamous cell carcinoma but not on the sarcoma. W e found that bleomycin A 2 is taken by this carcinoma at 4 times higher concentration than by the sarcoma, and in the carcinoma 60 per cent of bleomycin A 2 remained in the active form after one hour of the injection, but none of the active form was detected in the sarcoma. Thus, the selective effect on the squamous cell carcinoma was shown to be due to the high concentration of bleomycin in this tumour and the low activity of this tumour to inactivate bleomycin. Rapid inactivation of bleomycin in liver, kidney etc., other than in lung and skin, was shown by our experiments, testing the distribution of 3 H -bleomycin among organs. Recently we found an enzyme in tissues to inactivate bleomycin. The distribution ofthis enzyme must be one mechanism of the selective effect. Table 3 . Each organwas homogenized with phosphate buffer (pH 6.8, 1/15M) of 3 times the weight of the organ, centrifuged at 900 g and bleomycin was added at 1000 J..Lg/ml. After 30 minutes at 37°C, the residual bleomycin was determined by the paper disc method. The faster inactivation in liver, kidney and spieen, than in Jung and skin, conforms with the results obtained by injection of 3 Hbleomycin A 2 • In the case when 3 H-bleomycin A 2 was injected and after one hour bleomycin A 2 in organs was determined by the radioactivity and the antibacterial activity; the presence of inactivated bleomycin A 2 in all organs was shown by the radioactivity but the bleomycin A 2 shown by the antibacterial activity was found only in the lung, skin and kidney. The bleomycin A 2 in kidney is due to the urine containing this antibiotic at a high concentration. Thus, the rapid inactivation in organs, except lung and skin, in vivo was shown by the distribution of 3 H-bleomycin A 2 . Therefore, the mechanism of inactivation by organ homogenates must give useful information on the mechanism of the selective activity. We could isolate an enzyme from various argans to inactivate bleomycins. Tentatively we defined a unit of the enzyme activity as follows: the enzyme was incubated with 100-250 ~gjml of bleomycin B 2 in 1j15M phosphate buffer at pH 7.2 for 60 minutes, and the enzyme activity to inactivate 1 J..Lg of bleomycin B 2 per minute was defined as one unit. Starting from 23 g of mice liver which was homogenized with 70 ml of 1/15M phosphate buffer, 70 mg, as protein, of the partially purified enzyme was prepared by the procedure shown in Table 4 .
The optimum pH ofthe enzymewas 7-7.5, and the optimum temperature was around 37°C. This enzyme, purified by DEAE cellulose chromatography, was very unstable. Therefore, the enzyme obtained by Sephadex G-25 chromatography was employed for the experiments. The standard condition was as follows: 1.2 mg of the enzyme, as protein, was incubated with 100 ~g/ml of a bleomycin and after 60 minutes the bleomycin, inactivated, was determined by the paper disc method using B. subtilis. As shown in Figure 11 , B 2 was more rapidly inactivated than A 2 and A 5 • After the inactivation, ammonia was determined by the Conway microdiffusion method followed by titration or by spectrometry after ninhydrin reaction. Then, one mole of ammonia was confirmed to be released during the inactivation. We attempted to isolate the inactivated bleomycin B 2 to find the chemical difference from bleomycin B 2 . Two hundred mg of b,)eomycin B 2 was incubated with 40 ml of the enzyme solution (1600 mg as protein) and 60 ml of 1/15M phosphate buffer for one hour at 37°C. 100 ml of methanol was added and the supernatant was concentrated to 20 ml; the inactivated and the residual bleomycins were adsorbed on IRC-50 resin in H+ form and eluted with 0·05N hydrochloric acid-acetone (1: 1). After neutralization with IR-45 resin in OH-form, the eluate was evaporated in vacuo to dryness. The powder was dissolved in 50 ml of distilled water and passed through a CM-Sephadex C-25 column (240 ml) and the inactivated ·and the residual bleomycins were eluted by raising the concentration of ammonium formate from 0·05M to l·OM. The pattern of the elution is shown in Figure 12 . The eluate was treated by carbon chromatography using 0·02M hydrochloric acid-n-propanol The antibacterial activity of the inactivated B 2 is shown in Table 5 , compared with bleomycin B 2 • Except for the effect against Mycobacterium 607 and Salmonella enteritidis, its solution at 100 J.lgjml showed no antibacterial activity. lt caused 50 per cent inhibition of Y oshida rat sarcoma cells at at 200 J.lg/ml and bleomycin B 2 showed the inhibition at 2.5 J.lg/ml. The difference between the inactivated B 2 and bleomycin B 2 was found in the slightly lower basicity shown by high valtage electrophoresis. Hydrolysis in 6N hydrochloric acid for 24 hours gave all the degradation products obtained from bleomycin B 2 • As already described, during the enzymatic inactivation, one male of ammonia was released. Therefore, the sugar moiety was tested by gas chromatography of the trimethylsilyl derivatives of the methanolysis products. The carbamoyl group was also confirmed in the inactivated bleomycin B 2 . These data suggest that ammonia would be released from carboxyl amide. However, wehavenot yet obtained direct proof of a free carboxyl group in the inactivated bleomycin.
In vivo, bleomycin A 5 is rapidly inactivated, but in tissue homogenates it is much more resistant than bleomycin B 2 . This suggests the presence of another enzyme reducing the activity of A 5 . However, the enzyme that was described above is thought to have a role in sblective toxicity because this enzyme is strong in liver, kidney, and spieen and weak in skin and lung and inactivates all the bleomycins tested.
